Search details
1.
Evaluation of Miracle Mouthwash plus Hydrocortisone Versus Prednisolone Mouth Rinses as Prophylaxis for Everolimus-Associated Stomatitis: A Randomized Phase II Study.
Oncologist
; 24(9): 1153-1158, 2019 09.
Article
in English
| MEDLINE | ID: mdl-30833486
2.
Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer.
BMC Cancer
; 19(1): 578, 2019 Jun 13.
Article
in English
| MEDLINE | ID: mdl-31195996
3.
Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial.
Lancet Oncol
; 19(4): 497-509, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29501363
4.
A phase 2 safety study of accelerated elotuzumab infusion, over less than 1 h, in combination with lenalidomide and dexamethasone, in patients with multiple myeloma.
Am J Hematol
; 92(5): 460-466, 2017 May.
Article
in English
| MEDLINE | ID: mdl-28213943
5.
Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer.
Breast Cancer Res Treat
; 146(2): 321-8, 2014 Jul.
Article
in English
| MEDLINE | ID: mdl-24699910
6.
Long-term patient-reported outcomes from monarchE: Abemaciclib plus endocrine therapy as adjuvant therapy for HR+, HER2-, node-positive, high-risk, early breast cancer.
Eur J Cancer
; 199: 113555, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38244363
7.
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
J Clin Oncol
; 42(3): 283-299, 2024 Jan 20.
Article
in English
| MEDLINE | ID: mdl-37864337
8.
Evaluation of cell-free DNA approaches for multi-cancer early detection.
Cancer Cell
; 40(12): 1537-1549.e12, 2022 12 12.
Article
in English
| MEDLINE | ID: mdl-36400018
9.
Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer.
Breast Cancer Res Treat
; 126(1): 101-8, 2011 Feb.
Article
in English
| MEDLINE | ID: mdl-21188632
10.
Efficacy and Safety of Weekly Paclitaxel With or Without Oral Alisertib in Patients With Metastatic Breast Cancer: A Randomized Clinical Trial.
JAMA Netw Open
; 4(4): e214103, 2021 04 01.
Article
in English
| MEDLINE | ID: mdl-33877311
11.
A Phase 2 Randomized Placebo-Controlled Adjuvant Trial of GI-4000, a Recombinant Yeast Expressing Mutated RAS Proteins in Patients with Resected Pancreas Cancer.
J Pancreat Cancer
; 7(1): 8-19, 2021.
Article
in English
| MEDLINE | ID: mdl-33786412
12.
Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer.
Breast Cancer Res Treat
; 118(2): 361-7, 2009 Nov.
Article
in English
| MEDLINE | ID: mdl-19459042
13.
Comutation of PIK3CA and TP53 in Residual Disease After Preoperative Anti-HER2 Therapy in ERBB2 (HER2)-Amplified Early Breast Cancer.
JCO Precis Oncol
; 3: 1-26, 2019 Dec.
Article
in English
| MEDLINE | ID: mdl-35100698
14.
Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients.
NPJ Breast Cancer
; 5: 36, 2019.
Article
in English
| MEDLINE | ID: mdl-31667338
15.
Phase II trial of gemcitabine/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancer.
Clin Breast Cancer
; 8(2): 178-86, 2008 Apr.
Article
in English
| MEDLINE | ID: mdl-18621615
16.
Five-year results of a phase II trial of preoperative 5-fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2-positive patients) for patients with stage II or III breast cancer.
Cancer Med
; 7(6): 2288-2298, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29582557
17.
The Rise of Post-Grant Proceedings.
ACS Med Chem Lett
; 8(1): 4-6, 2017 Jan 12.
Article
in English
| MEDLINE | ID: mdl-28105262
18.
Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial.
J Clin Oncol
; 35(10): 1041-1048, 2017 Apr 01.
Article
in English
| MEDLINE | ID: mdl-28113032
19.
Phase II, Multicenter, Single-Arm, Feasibility Study of Eribulin Combined With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive, Early-Stage Breast Cancer.
Clin Breast Cancer
; 16(1): 31-7, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26433876
20.
Case Studies in the Management of Metastatic Breast Cancer with Eribulin.
Clin Med Insights Oncol
; 9: 81-5, 2015.
Article
in English
| MEDLINE | ID: mdl-26508896